These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38285081)

  • 1. Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review.
    Wang Q; Zhao Y; Zang X; Zhou G; Liu Y; Feng Q; Li X; Wang W; Dong X; Liu X; Peng J; Liu C
    Ann Hematol; 2024 Mar; 103(3):999-1005. PubMed ID: 38285081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.
    Samhouri Y; Ursu S; Dutton N; Tanvi V; Fazal S
    J Oncol Pharm Pract; 2021 Jun; 27(4):990-995. PubMed ID: 32847479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blastic plasmacytoid dendritic cell tumor treated with DVT regimen: a case report and literature review].
    Shi J; Xu N; Niu Y; Jia SX; Yang CM; Fang MY
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):86-89. PubMed ID: 38527844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venetoclax Combined with Azacytidine Can Be a First-line Treatment Option for Elderly Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Nagate Y; Nakaya A; Kamimura R; Hirose Y; Nojima S; Fujita J; Kiyohara E; Shibayama H
    Intern Med; 2023; 62(17):2547-2551. PubMed ID: 37661416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daratumumab-based therapy after prior Azacytidine-Venetoclax in an octagenerian female with BPDCN (blastic plasmacytoid dendritic cell neoplasm) - a new perspective.
    Mirgh S; Sharma A; Folbs B; Khushoo V; Kapoor J; Tejwani N; Ahmed R; Agrawal N; Choudhary PS; Mehta P; Bhurani D
    Leuk Lymphoma; 2021 Dec; 62(12):3039-3042. PubMed ID: 34151693
    [No Abstract]   [Full Text] [Related]  

  • 6. Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm.
    Le Calloch R; Arnaud B; Le Clech L; Hutin P; Salmon F; Garnache Ottou F; Ianotto JC; Laribi K
    Ann Hematol; 2022 Jun; 101(6):1347-1349. PubMed ID: 35249131
    [No Abstract]   [Full Text] [Related]  

  • 7. Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax.
    Montero J; Stephansky J; Cai T; Griffin GK; Cabal-Hierro L; Togami K; Hogdal LJ; Galinsky I; Morgan EA; Aster JC; Davids MS; LeBoeuf NR; Stone RM; Konopleva M; Pemmaraju N; Letai A; Lane AA
    Cancer Discov; 2017 Feb; 7(2):156-164. PubMed ID: 27986708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm.
    He J; Garcia MB; Connors JS; Nuñez CA; Quesada AE; Gibson A; Roth M; Cuglievan B; Pemmaraju N; McCall D
    J Pediatr Hematol Oncol; 2023 Nov; 45(8):e1001-e1004. PubMed ID: 37661300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm.
    Piccini M; Loscocco GG; Gianfaldoni G; Grieco P; Palmieri G; Pilerci S; Scappini B; Bosi A
    Ann Hematol; 2020 Apr; 99(4):907-909. PubMed ID: 32030448
    [No Abstract]   [Full Text] [Related]  

  • 10. Venetoclax monotherapy for cutaneous blastic plasmacytoid dendritic cell neoplasm.
    Schwede M; Tan IT; Atibalentja DF; Dickman MM; Rieger KE; Mannis GN
    Ann Hematol; 2020 Dec; 99(12):2973-2975. PubMed ID: 32968828
    [No Abstract]   [Full Text] [Related]  

  • 11. Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature.
    Albiol N; Novelli S; Mozos A; Pratcorona M; Martino R; Sierra J
    J Med Case Rep; 2021 Jun; 15(1):326. PubMed ID: 34172079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With a Bcl-2 Inhibitor.
    Egger A; Coello D; Kirsner RS; Brehm JE
    J Drugs Dermatol; 2021 May; 20(5):550-551. PubMed ID: 33938687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Jain A; Sweet K
    J Natl Compr Canc Netw; 2023 May; 21(5):515-521. PubMed ID: 37156483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
    Lim MS; Lemmert K; Enjeti A
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report.
    Grushchak S; Joy C; Gray A; Opel D; Speiser J; Reserva J; Tung R; Smith SE
    Medicine (Baltimore); 2017 Dec; 96(51):e9452. PubMed ID: 29390581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss of CD123.
    Hu X; Ediriwickrema A; Saleem A; Tan B; Pemmaraju N; Mannis GN
    Leuk Res; 2024 Apr; 139():107479. PubMed ID: 38492495
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review.
    Wang Y; Xiao L; Yin L; Zhou L; Deng Y; Deng H
    Medicine (Baltimore); 2023 Feb; 102(7):e32904. PubMed ID: 36800625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123.
    Zanotta S; Galati D; De Filippi R; Pinto A
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutated ZRSR2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm.
    Fukuchi K; Koyama D; Takada M; Mori H; Hayashi K; Asano N; Sato Y; Fukatsu M; Takano M; Takahashi H; Shirado-Harada K; Kimura S; Yamamoto T; Ikezoe T
    Int J Hematol; 2023 Oct; 118(4):489-493. PubMed ID: 37029861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body.
    Cui XB; Jin J; Pang XL; Li S; Liu CX; Li TT; Peng H; Zhang SM; Li L; Liang WH; Chen YZ; Li F
    Int J Clin Exp Pathol; 2014; 7(7):4391-9. PubMed ID: 25120824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.